Loading...
Docoh

Eloxx Pharmaceuticals (ELOX)

Employees
Data from SEC filings
Employee count
ESG framework mentions
In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions
Shareholder alignment
Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

(a) The annual meeting of stockholders of Eloxx Pharmaceuticals, Inc. (the “Company”) was held on May 19, 2021.

(b) Stockholders voted on the matters set forth below:

Proposal 1. Election of Directors:

ForWithheldBroker Non-Votes
Tomer Kariv19,259,075937,3235,837,608
Sumit Aggarwal20,095,235101,1635,837,608
Zafrira Avnur, Ph.D.19,259,792936,6065,837,608
Ran Nussbaum18,926,4891,269,9095,837,608
Rajesh Parekh, DPhil20,136,16660,2325,837,608
Steven Rubin17,365,6492,830,7495,837,608
Jasbir Seehra, Ph.D.20,091,721104,6775,837,608
Gadi Veinrib20,093,317103,0815,837,608
Alan Walts, Ph.D.19,901,777294,6215,837,608

Proposal 2. Ratification of Appointment Deloitte & Touche LLP as the Company’s Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2021:

For25,998,455
Against9,022
Abstain26,529
Broker Non-Votes5,837,608

Proposal 3. Advisory Vote on Executive Compensation:

For20,065,552
Against98,341
Abstain32,505
Broker Non-Votes5,837,608

(c) Not applicable.

(d) Not applicable.